In total, for the neuroactive ligand receptor interaction pathway, CHRNA3 rs1051730 and CHRNB4 rs6495309 reached the criterion and were included for further analysis of the independent association and combined effects of SNPs on lung cancer risk. This evidence concerns the gene CHRNB4 and lung cancer.